Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Hansbauer EM"'
Autor:
Heinzelmann K; Translational Research, Pieris Pharmaceuticals GmbH, Germany., Fysikopoulos A; Translational Reserach, Pieris Pharmaceuticals GmbH, Germany., Jaquin TJ; Translational Research, Pieris Pharmaceuticals GmbH, Germany., Peper-Gabriel JK; Translational Research, Pieris Pharmaceuticals GmbH, Germany., Hansbauer EM; Translational Research, Pieris Pharmaceuticals GmbH, Germany., Grüner S; Translational Research, Pieris Pharmaceuticals GmbH, Germany., Prassler J; Translational Research, Pieris Pharmaceuticals GmbH, Germany., Wurzenberger C; Translational Research, Pieris Pharmaceuticals GmbH, Germany., Kennedy JGC; Marsico Lung Institute/Cystic Fibrosis Center, University of North Carolina at Chapel Hill, United States., Snead JY; Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Wrennall JA; Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Heinig K; Translational Research, Pieris Pharmaceuticals GmbH, Germany., Wurzenberger C; Translational Research, Pieris Pharmaceuticals GmbH, Germany., Bel Aiba RS; Translational Research, Pieris Pharmaceuticals GmbH, Germany., Tarran R; Division of Genetic, Environmental and Inhalational Disease, Department of Internal Medicine, Kansas University Medical Center, United States., Livraghi-Butrico A; Marsico Lung Institute/Cystic Fibrosis Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Fitzgerald MF; Translational Research, Pieris Pharmaceuticals GmbH, Germany., Anderson GP; Medicine/Pharmacology, University of Melbourne, Parkville, Victoria, Australia., Rothe C; Translational Research, Pieris Pharmaceuticals GmbH, Germany., Matschiner G; Respiratory Research, Pieris Pharmaceuticals, Hallbergmoos, Germany., Olwill SA; Translational Research, Pieris Pharmaceuticals GmbH, Germany., Hagner M; Translational Research, Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany.
Publikováno v:
American journal of physiology. Lung cellular and molecular physiology [Am J Physiol Lung Cell Mol Physiol] 2024 Nov 05. Date of Electronic Publication: 2024 Nov 05.
Autor:
Piha-Paul S; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Olwill SA; Pieris Pharmaceuticals, Freising, Germany., Hamilton E; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, Tennessee, United States., Tolcher A; South Texas Accelerated Research Therapeutics, San Antonio, TX, United States., Pohlmann P; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Liu SV; Georgetown University, Washington, DC, United States., Wurzenberger C; Pieris Pharmaceuticals, Hallbergmoos, Germany., Hasenkamp LC; Pieris Pharmaceuticals, Freising, Germany., Hansbauer EM; Pieris Pharmaceuticals, Hallbergmoos, Germany., Shroff R; University of Arizona, Tucson, AZ, United States., Hurvitz S; Fred Hutchinson Cancer Center, Seattle, WA, United States., Krishnamurthy A; Hillman Cancer Center, Pittsburgh, United States., Patnaik A; South Texas Accelerated Research Therapeutics, San Antonio, United States., Hahn N; Johns Hopkins School of Medicine, Baltimore, Maryland, United States., Kumar R; Pieris, Bavaria, Germany., Duerr M; Pieris Pharmaceuticals, Bavaria, Germany., Zettl M; CureVac (Germany), Tuebingen, Germany., Aviano K; Pieris Pharmaceuticals (United States), Massachusetts, United States., Matis L; Pieris Pharmaceuticals (United States), Massachusetts, United States., Bruns I; Bayer (United States), United States., Ku G; Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Sep 05. Date of Electronic Publication: 2024 Sep 05.
Autor:
Peper-Gabriel JK; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Pavlidou M; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Pattarini L; Institut de Recherches Servier, Center for Therapeutic Innovation Oncology, Croissy-sur-Seine, France., Morales-Kastresana A; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Jaquin TJ; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Gallou C; Institut de Recherches Servier, Center for Therapeutic Innovation Oncology, Croissy-sur-Seine, France., Hansbauer EM; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Richter M; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Lelievre H; Institut de Recherches Internationales Servier Oncology R&D Unit, Suresnes, France., Scholer-Dahirel A; Institut de Recherches Internationales Servier Oncology R&D Unit, Suresnes, France., Bossenmaier B; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Sancerne C; Institut de Recherches Servier, Center for Therapeutic Innovation Oncology, Croissy-sur-Seine, France., Riviere M; Institut de Recherches Servier, Center for Therapeutic Innovation Oncology, Croissy-sur-Seine, France., Grandclaudon M; Institut de Recherches Servier, Center for Therapeutic Innovation Oncology, Croissy-sur-Seine, France., Zettl M; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Bel Aiba RS; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Rothe C; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Blanc V; Institut de Recherches Servier, Center for Therapeutic Innovation Oncology, Croissy-sur-Seine, France., Olwill SA; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Aug 02; Vol. 28 (15), pp. 3387-3399.
Autor:
Siegemund M; Institute of Cell Biology and Immunology, University of Stuttgart, Stuttgart, Germany., Oak P; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Hansbauer EM; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Allersdorfer A; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Utschick K; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Winter A; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Grasmüller C; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Galler G; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Mayer JP; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Weiche B; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Prassler J; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Kontermann RE; Institute of Cell Biology and Immunology, University of Stuttgart, Stuttgart, Germany.; Stuttgart Research Center Systems Biology, University of Stuttgart, Stuttgart, Germany., Rothe C; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2021 Oct 25; Vol. 12, pp. 759337. Date of Electronic Publication: 2021 Oct 25 (Print Publication: 2021).
Autor:
Worbs S; Biological Toxins, Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Seestr. 10, 13353 Berlin, Germany., Kampa B; Biological Toxins, Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Seestr. 10, 13353 Berlin, Germany., Skiba M; Biological Toxins, Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Seestr. 10, 13353 Berlin, Germany., Hansbauer EM; Biological Toxins, Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Seestr. 10, 13353 Berlin, Germany.; Département Médicaments et Technologies pour la Santé, Université Paris Saclay, CEA, INRAE, SPI, 91191 Gif-sur-Yvette, France., Stern D; Biological Toxins, Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Seestr. 10, 13353 Berlin, Germany., Volland H; Département Médicaments et Technologies pour la Santé, Université Paris Saclay, CEA, INRAE, SPI, 91191 Gif-sur-Yvette, France., Becher F; Département Médicaments et Technologies pour la Santé, Université Paris Saclay, CEA, INRAE, SPI, 91191 Gif-sur-Yvette, France., Simon S; Département Médicaments et Technologies pour la Santé, Université Paris Saclay, CEA, INRAE, SPI, 91191 Gif-sur-Yvette, France., Dorner MB; Biological Toxins, Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Seestr. 10, 13353 Berlin, Germany., Dorner BG; Biological Toxins, Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Seestr. 10, 13353 Berlin, Germany.
Publikováno v:
Toxins [Toxins (Basel)] 2021 Apr 18; Vol. 13 (4). Date of Electronic Publication: 2021 Apr 18.
Autor:
von Berg L; Biological Toxins (ZBS 3), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, 13353, Germany., Stern D; Biological Toxins (ZBS 3), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, 13353, Germany., Pauly D; Biological Toxins (ZBS 3), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, 13353, Germany.; Department of Ophthalmology, University Hospital Regensburg, Regensburg, 93053, Germany., Mahrhold S; Institut für Toxikologie, Medizinische Hochschule Hannover, 30625, Hannover, Germany., Weisemann J; Institut für Toxikologie, Medizinische Hochschule Hannover, 30625, Hannover, Germany., Jentsch L; Biological Toxins (ZBS 3), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, 13353, Germany., Hansbauer EM; Biological Toxins (ZBS 3), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, 13353, Germany., Müller C; Spiez Laboratory, Federal Office for Civil Protection, Spiez, 3700, Switzerland., Avondet MA; Spiez Laboratory, Federal Office for Civil Protection, Spiez, 3700, Switzerland., Rummel A; Institut für Toxikologie, Medizinische Hochschule Hannover, 30625, Hannover, Germany., Dorner MB; Biological Toxins (ZBS 3), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, 13353, Germany., Dorner BG; Biological Toxins (ZBS 3), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, 13353, Germany. DornerB@rki.de.
Publikováno v:
Scientific reports [Sci Rep] 2019 Apr 02; Vol. 9 (1), pp. 5531. Date of Electronic Publication: 2019 Apr 02.
Autor:
Hansbauer EM; Service de Pharmacologie et Immunoanalyse (SPI), Laboratoire d'Etude du Métabolisme des Médicaments, CEA, INRA, Université Paris Saclay , F-91191 Gif-sur-Yvette cedex, France., Worbs S; Biological Toxins, Centre for Biological Threats and Special Pathogens, Robert Koch Institute , Berlin, Germany., Volland H; Service de Pharmacologie et Immunoanalyse (SPI), Laboratoire d'Etudes et de Recherches en Immunoanalyse, CEA, INRA, Université Paris Saclay , F-91191 Gif-sur-Yvette cedex, France., Simon S; Service de Pharmacologie et Immunoanalyse (SPI), Laboratoire d'Etudes et de Recherches en Immunoanalyse, CEA, INRA, Université Paris Saclay , F-91191 Gif-sur-Yvette cedex, France., Junot C; Service de Pharmacologie et Immunoanalyse (SPI), CEA, INRA, Université Paris Saclay , F-91191 Gif-sur-Yvette cedex, France., Fenaille F; Service de Pharmacologie et Immunoanalyse (SPI), Laboratoire d'Etude du Métabolisme des Médicaments, CEA, INRA, Université Paris Saclay , F-91191 Gif-sur-Yvette cedex, France., Dorner BG; Biological Toxins, Centre for Biological Threats and Special Pathogens, Robert Koch Institute , Berlin, Germany., Becher F; Service de Pharmacologie et Immunoanalyse (SPI), Laboratoire d'Etude du Métabolisme des Médicaments, CEA, INRA, Université Paris Saclay , F-91191 Gif-sur-Yvette cedex, France.
Publikováno v:
Analytical chemistry [Anal Chem] 2017 Nov 07; Vol. 89 (21), pp. 11719-11727. Date of Electronic Publication: 2017 Oct 20.
Autor:
Hansbauer EM; Biological Toxins, Centre for Biological Threats and Special Pathogens, Robert Koch Institute (RKI), Berlin, Germany. DornerB@rki.de., Skiba M, Endermann T, Weisemann J, Stern D, Dorner MB, Finkenwirth F, Wolf J, Luginbühl W, Messelhäußer U, Bellanger L, Woudstra C, Rummel A, Fach P, Dorner BG
Publikováno v:
The Analyst [Analyst] 2016 Sep 21; Vol. 141 (18), pp. 5281-97. Date of Electronic Publication: 2016 Jun 29.
Autor:
Woudstra C; Anses (French Agency for Food, Environmental and Occupational Health and Safety), Food Safety Laboratory, Maisons-Alfort, France., Le Maréchal C; Anses, Ploufragan-Plouzané Laboratory, Hygiene and Quality of Poultry and Pig Products Unit, Ploufragan, France Université Européenne de Bretagne, Rennes, France., Souillard R; Anses, Ploufragan-Plouzané Laboratory, Hygiene and Quality of Poultry and Pig Products Unit, Ploufragan, France Université Européenne de Bretagne, Rennes, France., Bayon-Auboyer MH; LABOCEA, Ploufragan, France., Anniballi F; Istituto Superiore di Sanità (ISS) Department of Veterinary Public Health and Food Safety, National Reference Centre for Botulism, Rome, Italy., Auricchio B; Istituto Superiore di Sanità (ISS) Department of Veterinary Public Health and Food Safety, National Reference Centre for Botulism, Rome, Italy., De Medici D; Istituto Superiore di Sanità (ISS) Department of Veterinary Public Health and Food Safety, National Reference Centre for Botulism, Rome, Italy., Bano L; Istituto Zooprofilattico Sperimentale delle Venezie (IZSVe), Laboratorio di Treviso, Treviso, Italy., Koene M; Central Veterinary Institute (CVI) of Wageningen, UR, Lelystad, The Netherlands., Sansonetti MH; LNC, Veterinary Diagnostic Laboratory, Paita, New Caledonia., Desoutter D; LNC, Veterinary Diagnostic Laboratory, Paita, New Caledonia., Hansbauer EM; Robert Koch-Institut (RKI) Centre for Biological Threats and Special Pathogens, Biological Toxins, Consultant Laboratory for Clostridium botulinum, Berlin, Germany., Dorner MB; Robert Koch-Institut (RKI) Centre for Biological Threats and Special Pathogens, Biological Toxins, Consultant Laboratory for Clostridium botulinum, Berlin, Germany., Dorner BG; Robert Koch-Institut (RKI) Centre for Biological Threats and Special Pathogens, Biological Toxins, Consultant Laboratory for Clostridium botulinum, Berlin, Germany., Fach P; Anses (French Agency for Food, Environmental and Occupational Health and Safety), Food Safety Laboratory, Maisons-Alfort, France patrick.fach@anses.fr.
Publikováno v:
Applied and environmental microbiology [Appl Environ Microbiol] 2015 Apr; Vol. 81 (7), pp. 2495-505. Date of Electronic Publication: 2015 Jan 30.